Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign

This publication has 10 references indexed in Scilit:

• A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing
  Proceedings of the National Academy of Sciences, 2004
• Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples
  Genetics in Medicine, 2002
• Lung Disease Associated with the IVS8 5T Allele of the CFTR Gene
  American Journal of Respiratory and Critical Care Medicine, 2000
• Functional Analysis of cis-Acting Elements Regulating the Alternative Splicing of Human CFTR Exon 9
  Human Molecular Genetics, 1999
• Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.
  Journal of Medical Genetics, 1998
• The diagnosis of cystic fibrosis: A consensus statement
  The Journal of Pediatrics, 1998
• Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
  Journal of Clinical Investigation, 1998
• CFTR gene variant for patients with congenital absence of vas deferens.
  1995
• Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens
  New England Journal of Medicine, 1995
• Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
  Nature Genetics, 1993